Objective To determine the time course of fecal calprotectin (FC) excretion in preterm infants in the first two weeks of life and to identify influencing factors of FC levels.To explore whether FC may be an useful marker for the identification of gastrointestinal conditions in preterm infants.Methods FC concentration was measured using ELISA in 141 samples (50-100 mg)obtained from 47 preterm infants(gestational age less than 32 weeks or birth weight less than 1 200 grams)at birth,on day 7 and on day 14(The following was called FC1,FC2 and FC3 level for short).Results FC3 level was significantly higher than FC1 and FC2 levels (P ＜0.05),there were no significant differences between FC1 and FC2 levels in the 47 preterm infants(P ＞ 0.05).The FC1 level in infants whose mothers had antenatal infection was significantly higher(P ＜ 0.05).The FC2 level was negatively correlated with the antibiotic courses(r =-0.325,P ＜ 0.05).The FC2 level in infants with feeding intolerance was significantly lower than that in infants with feeding tolerance(P ＜ 0.05).The FC2 level in infants with feeding tolerance and the FC3 level in infants with feeding intolerance were positively correlated with the volume of enteral feeds,respectively (r =0.433,0.479,P ＜ 0.05).Contusion Antenatal infection and postnatal enteral feeds may lead to an increase in the excretion of FC in preterm infants.FC level was associated with enteral feeding and may be a useful marker for evaluation of gastrointestinal function in preterm infants.

Since last century, drug discovery efforts mostly focus on searching for chemicals which can inhibit some specific steps in a well-described disease pathway. However, this kind of highly specific inhibitors can not be effective for complex diseases, like cancer, diabetes, schizophrenia and mental illness. Therefore, we need to rethink the drug discovery and therapeutic strategies. In this review, the strategies of selection of cellular signal transduction networks and their dynamics as the targets for drug discovery and pharmacological treatments will be discussed. The properties and analytical methods of these signal transduction networks, internet sources and software tools for performing these strategies will be described. Strategies and procedures of using network-based drug discovery will be emphasized, including multi-targets drug design and network-based drug discovery.

Since last century, drug discovery efforts mostly focus on searching for chemicals which can inhibit some specific steps in a well-described disease pathway. However, this kind of highly specific inhibitors can not be effective for complex diseases, like cancer, diabetes, schizophrenia and mental illness. Therefore, we need to rethink the drug discovery and therapeutic strategies. In this review, the strategies of selection of cellular signal transduction networks and their dynamics as the targets for drug discovery and pharmacological treatments will be discussed. The properties and analytical methods of these signal transduction networks, internet sources and software tools for performing these strategies will be described. Strategies and procedures of using network- based drug discovery will be emphasized, including multi-targets drug design and network-based drug discovery.

Objective To develop an analytical method by gas chromatograph-mass spectrometry(GC-MS) for the determination of organic chloride pesticides and polycyclic aromatic hydrocarbons in prophyra Methods The samples were extracted by an acetone-hexane(7∶3,V/V) mixture first,then were purified by C18 solid-phase extraction(SPE),and then were determined with GC-MS.Results The linear range was 0.01-5.0 ?g/ml,the limits of detection were 0.05-0.32 ng/g(dry weight) and 0.25-0.56 ng/g(dry weight)for organic chloride pesticides and polycyclic aromatic hydrocarbons respectively.The recovery rates and relative standard deviation for organic chloride pesticides were 74.27%-121.49% and 3.19 %-17.31% relatively;the recovery rates and relative standard deviation for polycyclic aromatic hydrocarbons were 65.10%-119.26% and 2.75%-14.11% relatively.Organic chloride pesticides were partly detected,but the detection rate of polycyclic aromatic hydrocarbons was higher.Fifteen polycyclic aromatic hydrocarbons were detected in all samples but dibenz(a,h)-anthracene.Conclusion This method is sensitive,accurate and applicable to the determination of organic chloride pesticides and polycyclic aromatic hydrocarbons in prophyra.

OBJECTIVE:To improve the testing method of the related substances in nifedipine sustained-release tablets (Ⅰ).METHODS:The chromatographic condition was in line with the "State Drug Standard".In computing the contents of foreign substances,the standard of "it is negligible if the peak area of foreign substances was less than 10% of the peak area of Nifedipine in the standard solution" was improved to be "it is negligible if the peak area of foreign substances was less than 2%of the peak area of Nifedipine in the standard solution".RESULTS:The contents of the foreign substances determined in accordance with the "National Drug Standard" weresignificantly different from those determined by the improved method (0.00%,0.08%,0.29%,0.14 % vs.0.10%,0.21%,0.51%,0.27%,respectively).CONCLUSION:The improved method can help improve the standard drug quality in that the contents of the foreign substances can be strictly kept under control.

Objective To investigate the incidence of adult epilepsy patients with attention-deficit hyperactivity disorder (ADHD) and the characteristics of ADHD subtypes, and to explore the correlations between several epilepsy-related factors and ADHD. Methods According to corresponding inclusion criteria and exclusion criteria, 82 adult epilepsy patients from March 2012 to March 2016 were enrolled as study group. Eighty-two healthy adults were enrolled as the control group. Using the Chi-square test and Logistic regression analysis and the other statistical methods, the phenomenon of ADHD in adults with epilepsy and the factors that may contribute to the phenomenon was analyzed. Results The detection rate of ADHD in 82 adult patients with epilepsy was 26.8%(22/82), significantly higher than that in the heathly control group which was 4.9%(4/82),χ2=18.672, P<0.05. Symptomatic epilepsy 8/17 and the electroencephalogram showed multifocal discharge 6/14 had higher detection rate of comorbid ADHD and the difference was statistically significant (P<0.01). The results of binary Logistic regression analysis showed that epilepsy age of onset was possibly an important factor for epilepsy with ADHD (B=-0.891, P<0.05). Conclusions The risk of ADHD in adults with epilepsy is higher than that in the healthy adults and attention-deficit is the common subtype. The etiology, age of onset and electroencephalogram features of adults with epilepsy may be associated with the occurrence of ADHD.

Aorta, Thoracic ; abnormalities ; Humans ; Infant ; Magnetic Resonance Angiography ; Male ; Pulmonary Artery ; abnormalities ; Recurrence ; Respiratory Insufficiency ; etiology ; Respiratory Sounds ; etiology ; Subclavian Artery ; abnormalities ; Vascular Diseases ; complications ; congenital ; diagnosis ; pathology ; physiopathology

With the concept of vascular cognitive impairment has been deeply recognized and the thorough studies of its pathogenesis,study reports on vascular cognitive impairment have been increasing in recent years.This article reviews the molecular mechanism and genetics of vascular cognitive impairment.

AIM: To evaluate the correlation between in vitro release and in vivo absorption of aniracetam in conventional tablets and self-emulsifying drug delivery system (SEDDS), to investigate pharmacokinetics of aniracetam self-emulsifying drug delivery system and conventional tablets of aniracetam after oral administration to rats. METHODS: Dissolution behavior of these formulations was evaluated in vitro to assess the properties of dosage forms. And a new RP-HPLC method was developed for the in vivo quantitative determination of 4-p-anisamidobutyric acid (PABA), the active metabolite of aniracetam. To approach the in vitro-in vivo correlation, fraction absorbed in vivo (f) was calculated by Wagner-Nelson method, and then compared with in vitro released drug percentages (Q%). RESULTS: Aniracetam was released rapidly from SEDDS with 80%±4% of accumulation dissolution rate compared to that from conventional tablets at 15 min. The recovery of active metabolite of aniracetam was about 90%, and the intra-days and inter-day precision were within 4% and 6%, respectively. The AUC0-∞ value of aniracetam SEDDS was (11 168±2 395) ng·mL-1·h, which was about 3 folds greater than conventional tablets. The parameter MRT0-∞ of aniracetam SEDDS and conventional tablets were (2.7±0.6) h and (1.7±0.6) h, respectively, and the difference was statistically significant(P<0.05). The linear equation of in vitro-in vivo correlation for conventional tablets was obtained by regression as well. Whereas nonlinear correlation was obtained for aniracetam SEDDS, which fitted the quadric model very well and the correlation coefficient was 0.972. CONCLUSION: Aniracetam can be released faster from SEDDS than that from conventional tablets, and SEDDS improved the bioavailability of aniracetam significantly. The SEDDS composed by oil and compound surfactants which could enhance the absorption showed the expressing rate of dissolution, and those formed the o/w microemulsion with gastrointestinal liquid could absorb through lymphatic transport route.